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ABSTRACT
Introduction. The postoperative systemic inflammatory
response (SIR) is related to both long- and short-term
outcomes following surgery for colorectal cancer. How-
ever, it is not clear which clinicopathological factors are
associated with the magnitude of the postoperative SIR.
The present study was designed to determine the clinico-
pathological determinants of the postoperative systemic
inflammatory response following colorectal cancer
resection.
Methods. Patients with a histologically proven diagnosis
of colorectal cancer who underwent elective, potentially
curative resection during a period from 1999 to 2013 were
included in the study (n = 752). Clinicopathological data
and the postoperative SIR, as evidenced by postoperative
Glasgow Prognostic Score (poGPS), were recorded in a
prospectively maintained database.
Results. The majority of patients were aged 65 years or
older, male, were overweight or obese, and had an open
resection. After adjustment for year of operation, a high
day 3 poGPS was independently associated with American
Society of Anesthesiologists (ASA) grade (hazard ratio
[HR] 1.96; confidence interval [CI] 1.25–3.09; p = 0.003),
body mass index (BMI) (HR 1.60; CI 1.07–2.38;
p = 0.001), mGPS (HR 2.03; CI 1.35–3.03; p = 0.001),
and tumour site (HR 2.99; CI 1.56–5.71; p\ 0.001). After
adjustment for year of operation, a high day 4 poGPS was
independently associated with ASA grade (HR 1.65; CI
1.06–2.57; p = 0.028), mGPS (HR 1.81; CI 1.22–2.68;
p = 0.003), NLR (HR 0.50; CI 0.26–0.95; p = 0.034), and
tumour site (HR 2.90; CI 1.49–5.65; p = 0.002).
Conclusions. ASA grade, BMI, mGPS, and tumour site
were consistently associated with the magnitude of the
postoperative systemic inflammatory response, evidenced
by a high poGPS on days 3 and 4, in patients undergoing
elective potentially curative resection for colorectal cancer.
Colorectal cancer is the second most common cause of
cancer death in the United Kingdom, accounting for 16,000
deaths annually.1 It has been recognised that the preoper-
ative systemic inflammatory response is related to long-
term outcome in patients following potentially curative
surgery for colorectal cancer.2–4
It also has been reported that the postoperative systemic
inflammatory response can be a useful early predictor of
the development of postoperative infective complications
and anastomotic leak following colorectal cancer resection,
regardless of surgical approach.5–8 Indeed, C-reactive
protein (CRP) concentrations[150 mg/L on postoperative
days 3–5 have been consistently reported to be associated
with postoperative complications.9 With this in mind, a
postoperative systemic inflammation score, based on the
combination of CRP and albumin was developed and ter-
med the postoperative Glasgow Prognostic Score (poGPS).
This score recently has been reported to predict the
development and severity of postoperative infective com-
plications as well as long-term survival.10
With the expansion in the use of enhanced recovery
after surgery (ERAS) programmes to improve short-term
outcomes following surgery and promote timely discharge,
ERAS programmes have been proposed to reduce the
surgical stress response. However, in a recent systematic
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review, it was concluded that of the components of an
ERAS programme, only the use of laparoscopic surgery
was consistently associated with a lower postoperative
systemic inflammatory response.11 Therefore, clinico-
pathological factors that influence the postoperative
systemic inflammatory response, as evidenced by the
poGPS, are of considerable interest, because they may be
modifiable and therefore potentially could be considered as
future therapeutic targets. The purpose of the present study
was to examine the clinicopathological determinants of the
postoperative systemic inflammatory response, as evi-
denced by the poGPS on postoperative days 3 and 4, in
patients following resection of colorectal cancer.
METHODS
Patients with a histologically proven diagnosis of col-
orectal cancer who, based on preoperative investigations
and operative findings, were considered to have undergone
potentially curative resection at a single centre during a
period from 1999 to 2013 were initially included in the
study (n = 834). All procedures were performed at Glas-
gow Royal Infirmary, a University teaching hospital where
procedures were performed by consultant surgeons with a
subspecialist interest in colorectal surgery or by trainees
who were supervised by these consultants. Patient charac-
teristics, including perioperative C-reactive protein
concentrations, were recorded routinely in a prospective
departmental audit database. All patient data were
anonymised.
All tumours were staged according to the conventional
tumour, node, metastasis (TNM, 5th edition) classification.
Patients with metastatic disease were excluded from anal-
ysis. Daily blood samples were obtained, as per hospital
routine, during the perioperative period and were standard
care for all patients. Before surgery, all patients received
thromboprophylaxis and antibiotic prophylaxis as per
hospital policy at the time. Lesions from the caecum to the
sigmoid colon were classified as colon cancers, lesions of
the rectosigmoid junction and rectum were classified as
rectal cancers.
The preoperative systemic inflammatory response was
assessed using the modified Glasgow Prognostic Score
(mGPS), an extensively validated and independently
prognostic systemic inflammation based score. Briefly,
mGPS patients with a normal C-reactive protein (\10 mg/
L) were allocated a score of 0, those with an elevated
C-reactive protein ([10 mg/L) allocated a score 1, and
those with an elevated C-reactive protein ([10 mg/L) and
hypoalbuminaemia (\35 g/L) were allocated a score of 2.
The poGPS was calculated as previously described by
Watt et al.19 and is as follows: postoperative CRP
concentration \150 mg/L, regardless of albumin concen-
tration, scored 0; CRP concentration [150 mg/L and
albumin [25 g/L scored 1; and CRP [150 mg/L and
albumin \25 g/L scored 2. Emergency presentation was
determined if the patient presented via an unplanned hos-
pital admission and underwent surgery during the same
admission.
Patient comorbidity was classified using the American
Society of Anesthesiologists (ASA) grading system: 1
represents a normal healthy patient, 2 is a patient with mild
systemic disease, 3 is a patient with severe systemic dis-
ease, and 4 is a patient with severe systemic disease that is
a constant threat to life. This assessment was performed by
an anaesthetist preoperatively. Body mass index (BMI) was
categorised as normal weight (\25), overweight (C25–30),
and obese ([30). BMI was obtained from the patients’
electronic preoperative assessment record and ASA grade
from the Opera Theatre Management system (OPERA
v4.0, CHCA, Canada). The study was approved by the
West of Scotland Research Ethics Committee, Glasgow.
Statistical Analysis
The relationship between clinicopathological variables
and days 3 and 4 poGPS were examined using the v2 test
for categorical variables. Binary logistic regression was
used to examine the relationship between clinicopatho-
logical factors and the presence of a postoperative systemic
inflammatory response, indicated by a poGPS score of[1
on both days 3 and 4 and calculate an OR and 95% CI.
Clinicopathological factors that on univariate analysis had
a p value\0.10 were taken into a multivariate model using
a backward conditional model to identify independently
significant factors. A p value of \0.05 was considered
significant. Statistical analysis was performed using SPSS
version 22.0 for Windows (IBM Corporation, Armonk,
NY).
RESULTS
Baseline characteristics of the 752 patients who under-
went surgery for colorectal cancer are shown in Table 1.
The majority of patients were aged 65 years or older
(64%), male (54%), were overweight or obese (58%), had
colonic tumours (62%), were not systemically inflamed
(68% mGPS 0; 52% NLR B3), and had node-negative
disease (63%). Most patients underwent open resection
(85%). Overall, 23% of patients developed an infective
complication.
The relationships between days 3 and 4 poGPS and
clinicopathological characteristics are shown in Table 2.
The day 3 poGPS was significantly associated with male
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sex (p\ 0.05), later year of operation (p\ 0.001), ASA
grade (p\ 0.01), BMI (p\ 0.001), mGPS (p\ 0.001),
preop NLR (p\ 0.001), rectal cancer (p\ 0.01), laparo-
scopic surgery (p\ 0.01), and T stage (p\ 0.01). The day
4 poGPS was significantly associated with later year of
operation (p\ 0.001), BMI (p\ 0.05), mGPS (p\ 0.01),
NLR (p\ 0.005), and laparoscopic surgery (p\ 0.005).
Moreover, when year of operation was further divided into
three groups (1999–2003; 2004–2008; 2009–2013), the
poGPS of both day 3 and day 4 remained significantly
associated with year of operation (both p\ 0.001). The
day 3 poGPS was significantly associated with an increase
in infective complications from 12 to 31 to 45%, and the
day 4 poGPS was significantly associated with an increase
in infective complication rates from 16 to 39 to 58%.
Binary logistic regression of the factors significantly
associated with low poGPS (poGPS 0) versus a high
poGPS (poGPS 2) on day 3 and day 4 are shown in
Tables 3 and 4 respectively. A high day 3 poGPS was
independently associated with year of operation (hazard
ratio [HR] 4.63; confidence interval [CI] 2.28–9.42;
p\ 0.001), ASA (HR 2.02; CI 1.25–3.26; p = 0.004),
mGPS (HR 1.97; CI 1.29–3.01; p = 0.002), tumour site
(HR 2.62; CI 1.32–5.17; p = 0.006), and laparoscopic
surgery (HR 0.20; CI 0.05–0.73; p = 0.015). When year of
operation was removed from the binary logistic regression
analysis, only ASA grade (HR 1.96; CI 1.25–3.09;
p = 0.003), BMI (HR 1.60; CI 1.07–2.38; p = 0.001),
mGPS (HR 2.03; CI 1.35–3.03; p = 0.001), and tumour
site (HR 2.99; CI 1.56–5.71; p\ 0.001) were indepen-
dently associated with a high day 3 poGPS.
A high day 4 poGPS was independently associated with
year of operation (HR 5.32; CI 2.49–11.34; p\ 0.001),
ASA (HR 1.61; CI 1.02–2.55; p = 0.043), mGPS (HR
1.98; CI 1.32–2.96; p = 0.001), NLR (HR 0.47; CI
0.24–0.93; p = 0.031), and tumour site (HR 2.97; CI
1.49–5.91; p = 0.002). When year of operation was
removed from the binary logistic regression analysis, only
ASA grade (HR 1.65; CI 1.06–2.57; p = 0.028), mGPS
(HR 1.81; CI 1.22–2.68; p = 0.003), NLR (HR 0.50; CI
0.26–0.95; p = 0.034), and tumour site (HR 2.90; CI
1.49–5.65; p = 0.002) were independently associated with
a high day 4 poGPS.
DISCUSSION
The results of the present study showed that, in elective
surgery, year of operation, ASA grade, the preoperative
modified Glasgow Prognostic Score (mGPS), and tumour
site were independently associated with the postoperative
systemic inflammatory response, as evidenced by the
poGPS on both postoperative days 3 and 4. Therefore, in a
large cohort, the present results establish the main clini-
copathological factors determining an elevated systemic
inflammatory response following elective potentially
curative resection for colorectal cancer.
In the present study, it was of interest that the more
recent time period (2007–2013) was significantly associ-
ated with a greater magnitude of the postoperative systemic
inflammatory response, as evidenced by the poGPS. This
was unexpected, because it might have been anticipated
that with more recent surgical and anaesthetic techniques
fewer patients would exceed poGPS thresholds. Indeed,
patients in the more recent time period had higher BMI
(p\ 0.001) and mGPS (p\ 0.001) values. This would
suggest that elective surgery for colorectal cancer is
increasingly being performed in obese and systemically
inflamed patients. However, these factors were adjusted for
in the present analysis, and it may be that other factors,
related or unrelated, account for the greater magnitude of
the postoperative systemic inflammatory response in the
more recent time period.
The present results may have implications for future
clinical care, particularly with respect to minimising the
magnitude of the postoperative systemic inflammatory
TABLE 1 Clinicopathological characteristics of patients undergoing
elective potentially curative, elective resection for colorectal cancer
(n = 752)
Characteristic No. of patients (%)
Age (\65/65–74/C 75) 245 (33)/272 (33)/235 (31)
Sex (female/male) 344 (46)/408 (54)
Year of operation (1999–2006/
2007–2013)
311 (41)/408 (54)
ASA (1/2/3/4)a 58 (11)/214 (42)/219 (42)/24
(5)
BMI (\25/[ 25–30/[30)b 186 (34)/223 (41)/131 (24)
TNM stage (0/I/II/III) 12 (2)/141 (19)/321 (43)/278
(37)
T stage (I/II/III/IV) 62 (8)/106 (14)/411 (55)/161
(21)
N stage (0/I/II) 474 (63)/206 (27)/72 (10)
Tumour site (colon/rectum) 467 (62)/285 (38)
Laparoscopic (no/yes) 640 (85)/112 (15)
Preop mGPS 498 (68)/134 (18)/100 (14)
Preop NLR (B3/[3) 391 (52)/358 (48)
Day 3 poGPS (0/1/2) 361 (53)/186 (27)/135 (20)
Day 4 poGPS (0/1/2) 439 (72)/87 (14)/86 (14)
Infective complications (no/yes) 580 (77)/169 (23)
ASA American Society of Anesthesiology Grading System; BMI body
mass index; mGPS modified Glasgow Prognostic score; TNM Tumour
Node Metastases; CRP C-reactive protein
a n = 516
b n = 540
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TABLE 2 The relationship between clinicopathological characteristics and postoperative days 3 and 4 poGPS in patients undergoing elective,
potentially curative surgery for colorectal cancer (n = 752)
Characteristic n Day 3 poGPS (0/1/2) p value Day 4 poGPS (0/1/2) p value
Age (year) 0.247 0.662
\65 245 117 (53)/62 (28)/41 (19) 135 (70)/28 (14)/31 (16)
65–74 272 120 (49)/76 (31)/47 (19) 155 (70)/35 (16)/30 (14)
C75 235 124 (57)/48 (22)/47 (21) 149 (75)/24 (12)/25 (13)
Sex 0.012 0.109
Female 344 181 (57)/69 (22)/66 (21) 200 (75)/29 (11)/38 (14)
Male 408 180 (49)/117 (32)/69 (19) 239 (69)/58 (17)/48 (14)
Year of operation \0.001 \0.001
1999–2006 311 160 (58)/87 (32)/28 (10) 196 (82)/28 (12)/14 (6)
2007–2013 441 201 (49)/99 (24)/107 (26) 243 (65)/59 (16)/72 (19)
Year of operation \0.001 \0.001
1999–2003 172 89 (61)/49 (33)/9 (6) 102 (84)/15 (12)/5 (4)
2004–2008 228 113 (52)/60 (28)/43 (20) 148 (76)/22 (11)/24 (12)
2009–2013 352 159 (50)/77 (24)/83 (26) 189 (64)/50 (17)/57 (19)
ASA 0.008 0.446
1 58 37 (72)/8 (16)/6 (12) 30 (79)/5 (13)/3 (8)
2 214 109 (56)/64 (33)/22 (11) 132 (75)/28 (16)/15 (9)
3 219 107 (51)/57 (27)/44 (21) 137 (71)/30 (16)/25 (13)
4 24 7 (33)/7 (33)/7 (33) 15 (68)/2 (9)/5 (23)
BMI \0.001 0.003
\25 186 103 (60)/33 (19)/35 (21) 97 (70)/15 (11)/26 (19)
[25–30 223 107 (53)/70 (35)/23 (12) 138 (73)/35 (19)/15 (8)
[30 131 45 (40)/39 (34)/29 (26) 62 (59)/25 (24)/18 (17)
mGPS \0.001 0.007
0 498 260 (56)/128 (28)/75 (16) 302 (74)/54 (13)/50 (12)
1 134 50 (41)/45 (37)/26 (22) 71 (68)/21 (20)/13 (12)
2 100 43 (48)/13 (14)/34 (38) 55 (61)/12 (13)/23 (26)
NLR \0.001 0.002
B3 391 177 (49)/122 (33)/66 (18) 216 (66)/60 (18)/51 (16)
[3 358 184 (59)/62 (20)/68 (21) 222 (78)/27 (10)/34 (12)
Tumour site 0.009 0.076
Colon 467 225 (54)/126 (30)/69 (16) 264 (72)/58 (16)/43 (12)
Rectum 285 136 (52)/60 (23)/66 (25) 175 (71)/29 (12)/43 (17)
Laparoscopic 0.006 0.002
No 640 299 (51)/158 (27)/127 (22) 390 (73)/66 (12)/79 (15)
Yes 112 62 (63)/28 (29)/8 (8) 49 (64)/21 (27)/7 (9)
T stage 0.007 0.578
I 62 23 (42)/26 (47)/6 (11) 31 (63)/11 (22)/7 (14)
II 106 61 (62)/23 (24)/14 (14) 62 (71)/16 (16)/11 (13)
III 411 186 (50)/102 (27)/85 (23) 241 (71)/48 (14)/49 (15)
IV 161 84 (58)/34 (23)/27 (19) 95 (75)/14 (11)/18 (14)
N stage 0.346 0.065
0 474 229 (53)/109 (25)/94 (22) 275 (72)/49 (13)/59 (15)
I 206 100 (54)/58 (31)/29 (15) 129 (75)/27 (16)/15 (9)
II 72 32 (51)/19 (30)/12 (19) 35 (60)/11 (19)/12 (21)
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response. For example, ASA and BMI are problematic
therapeutic targets in that it would be difficult to treat these
directly in the relatively short time between diagnosis and
elective surgery. However, the postoperative systemic
inflammatory response could be targeted. For example,
patients who have a high BMI or ASA may selectively
receive laparoscopic surgery and perioperative care that
minimises the postoperative systemic inflammatory
response. Included in such care would be the use of anti-
inflammatory agents such as corticosteroids.12,13 However,
such targeted perioperative care is in its infancy, and the
optimal timings, the agents, and the doses to minimise the
magnitude of the postoperative systemic inflammatory
response that will result in improved postoperative out-
comes remains to be determined.14
In the present study, an elevated BMI was associated with
an increased poGPS. To our knowledge, this relationship has
not been previously reported. However, a direct relationship
between BMI and C-reactive protein concentrations has been
widely reported and both are established risk factors for the
development of colorectal cancer.15 The mechanism
underlying the relationship between BMI and the magnitude
of the postoperative systemic inflammatory response is not
clear. However, it may be that surgical injury to an increased
amount of subcutaneous fat leads to a more profound sys-
temic inflammatory response. This relationship is worthy of
further study.
The laparoscopic surgical approach, compared with the
open approach, has been repeatedly shown to attenuate the
systemic inflammatory response.16–19 In the present study,
laparoscopic surgery was independently associated with the
postoperative SIR on day 3 but not day 4. The basis of this
differential response to laparoscopic surgery is not clear.
However, it may relate to the transient effect of this sur-
gical approach or the interaction between laparoscopic
surgery, ASA grade, and BMI. For example, patients who
undergo a laparoscopic resection for colon cancer may
have less comorbidity and be less obese. Indeed, it would
appear that the benefit of laparoscopic surgery is more
pronounced in the immediate postoperative period. The
TABLE 2 continued
Characteristic n Day 3 poGPS (0/1/2) p value Day 4 poGPS (0/1/2) p value
Infective complications \0.001 \0.001
No 580 316 (61)/129 (25)/74 (14) 364 (80)/53 (12)/36 (8)
Yes 169 42 (26)/57 (36)/61 (38) 72 (46)/34 (22)/50 (32)
ASA American Society of Anesthesiology Grading System; BMI body mass index; mGPS modified Glasgow Prognostic score
TABLE 3 Binary logistic regression of clinicopathological factors associated with low poGPS (poGPS 0) versus a high poGPS (poGPS 2) on
day 3 in patients undergoing elective, potentially curative resection for colorectal cancer (n = 752)
Characteristic Univariate analysis Multivariate analysis
HR (95% CI) p value HR (95% CI) p value
Age (\65/65–74/C75 year) 1.04 (0.81–1.32) 0.760 – –
Sex (female/male) 1.05 (0.71–1.56) 0.804 – –
Year of operation
(99–06/07–13)
3.04 (1.91–4.84) \0.001 4.63 (2.28–9.42) \0.001
ASA (1/2/3/4) 1.87 (1.31–2.69) 0.001 2.02 (1.25–3.26) 0.004
BMI
(\25/25–30/[30)
1.36 (1.02–1.80) 0.033 1.44 (0.94–2.20) 0.090
mGPS (0/1/2) 1.67 (1.30–2.15) \0.001 1.97 (1.29–3.01) 0.002
NLR (B3/[3) 0.99 (0.67–1.47) 0.965 – –
Tumour site
(colon/rectum)
1.58 (1.06–2.36) 0.024 2.62 (1.32–5.17) 0.006
Laparoscopic (no/yes) 0.30 (0.14–0.65) 0.002 0.20 (0.05–0.73) 0.015
T stage (I/II/III/IV) 1.09 (0.86–1.36) 0.482 – –
N stage (0/I/II) 0.86 (0.63–1.18) 0.348 – –
ASA American Society of Anesthesiology Grading System; BMI body mass index; mGPS modified Glasgow Prognostic score; HR hazard ratio;
CI confidence interval
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significance of this is not clear but perhaps highlights the
important role the systemic inflammatory response plays
early in the postoperative period. Given the increasing use
of the laparoscopic approach (approximately 45% of col-
orectal cancer resections) these relationships warrant
further study.20
The present study has some potential limitations that
should be considered. Many preoperative factors associated
with a greater postoperative systemic inflammatory
response, such as obesity, diabetes, and other comorbidi-
ties, are interrelated and therefore potential confounding is
an important issue in the analysis of the present study.
Nevertheless, an objective measurement of the postopera-
tive systemic inflammatory response, such as the poGPS,
will facilitate in future studies the dissection of factors that
have independent influence.
In conclusion, the mGPS, ASA grade, BMI, and tumour
site were independently associated with a greater magnitude
of the postoperative systemic inflammatory response in
patients undergoing elective surgery for colorectal cancer.
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